MANIKANDA RAJA: Open Payments
NPI 1730290321 · HEMET, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,420 in 66 payments from 22 companies in 2025. Trend: 2023 $1,743 · 2024 $1,110 · 2025 $1,420
Food & beverage: $1,420
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $275 |
| Novo Nordisk Inc | 10 | $162 |
| Lilly USA, LLC | 7 | $161 |
| ABBVIE INC. | 7 | $157 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $122 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $82 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $55 |
| Xeris Pharmaceuticals, Inc. | 2 | $45 |
| GlaxoSmithKline, LLC. | 2 | $42 |
| Amgen Inc. | 2 | $34 |
Products named: MOUNJARO, Kerendia, AIRSUPRA, UBRELVY, Wegovy, BREZTRI, XIFAXAN, JARDIANCE.
Industry payments across CA — which companies pay providers there.
